
(AGENPARL) – SILVER SPRING lun 24 aprile 2023 FDA authorized bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including an additional dose or doses for certain populations
Fonte/Source: http://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-bivalent-vaccines